Yesterday was a big day for Arthroventions as we celebrated our first sale by cutting my hair. I am so proud of our team and their hard work over the last year and a half. Launching a medical device company has been one of the hardest and most challenging endeavors we have all undertaken. Read more about Arthro CEO Takes a Haircut Or Why Your CEO Should Not Bet Your Sales Team[…]
On Thursday, Arthroventions reflected on customer discovery and validated learning as part of the National Science Foundation’s (NSF) Innovation Corps (I-Corps™) program, hosted by the Colorado Clinical and Translational Science Institute (CCTSI). The I-Corps program provides real-world, hands-on, immersive learning about what it takes to successfully commercialize products and services that customers want. During the Read more about Arthroventions Reflects on the NSF’s I-Corps Program and Customer Discovery[…]
In front of a packed auditorium at National Jewish Health, Dr. Rick Scheuring, NASA Flight Surgeon and Team Lead for Musculoskeletal, Sports Medicine and Rehabilitation, presented his work on treating US Astronauts and the impact of micro-gravity on musculoskeletal injuries. A major source of astronauts’ musculoskeletal injuries arises from the space suit design. NASA Read more about Dr. Rick Scheuring, NASA Flight Surgeon, Presents at National Jewish Health[…]
Dr. Rick Scheuring, NASA Flight Surgeon and Team Lead for Musculoskeletal, Sports Medicine and Rehabilitation, will be presenting his work on treating US Astronauts and the effects of micro-gravity on musculoskeletal injuries at National Jewish Health this Friday. Dr. Scheuring is also an integration lead for NASA’s Constellation program that will return humans to the Read more about NASA Flight Surgeon Presenting at National Jewish Health on Musculoskeletal Injuries in Astronauts[…]
Founder Eric Hoffman answers the judges' questions about @arthroventions's solution for joint care pic.twitter.com/evFY0cvlG4 — MedTech Innovator (@MedTechAwards) April 19, 2017 .@arthroventions uses 'snyoviomics' – biomarkers in the synovial fluid – to predict drug responsiveness for joint disease. pic.twitter.com/c5cMgIng7d — Vanessa Carmean (@vanessacarmean) April 19, 2017
Arthroventions™ is proud to announce that we have been selected as a MedTech Innovator Top 100 Company and had the opportunity to present at the Medtech Innovator Denver Pitch Event on April 19th. The Denver Pitch Event was hosted by the Colorado Bioscience Association at the University of Denver and featured pitches from local best-in-class Read more about Arthroventions selected as a MedTech Innovator Top 100 Company[…]